{"url":"https://lda.senate.gov/api/v1/filings/052d0739-93f3-4ac9-bbf3-f046fc46ba74/","filing_uuid":"052d0739-93f3-4ac9-bbf3-f046fc46ba74","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2014,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/052d0739-93f3-4ac9-bbf3-f046fc46ba74/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Daniel R. Murphy, General Counsel","dt_posted":"2014-10-20T17:55:27.027000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Thirteenth Street, NW","registrant_address_2":"Eleventh Floor South","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":5357,"url":"https://lda.senate.gov/api/v1/registrants/5357/","house_registrant_id":31564,"name":"BGR GOVERNMENT AFFAIRS","description":"Lobbying firm","address_1":"601 13th Street, NW","address_2":"11th Floor South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHELSEA MINCHEFF","contact_telephone":"+1 202-661-6385","dt_updated":"2026-01-30T13:07:06.930629-05:00"},"client":{"id":106628,"url":"https://lda.senate.gov/api/v1/clients/106628/","client_id":1006346,"name":"CHELSEA THERAPEUTICS","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":false,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-11-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Provide guidance and strategic counsel on federal regulatory policy and legislative issues affecting Chelsea's products.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58039,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":54906,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BOYER","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":56871,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"FAULKNER","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}